News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
718,641 Results
Type
Article (42680)
Company Profile (298)
Press Release (675663)
Multimedia
Podcasts (80)
Webinars (12)
Section
Business (210644)
Career Advice (2100)
Deals (36667)
Drug Delivery (108)
Drug Development (83126)
Employer Resources (176)
FDA (16601)
Job Trends (15440)
News (356407)
Policy (33952)
Tag
2024 BioCapital Digital (12)
2024 BioForest Digital (4)
2024 BioForest Standard (1)
2024 BioMidwest Digital (9)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (7)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (9)
2024 Biotech Beach Standard (6)
2024 Genetown Digital (8)
2024 Genetown Standard (10)
2024 Lone Star Bio Digital (5)
2024 Pharm Country Digital (6)
2024 Pharm Country Standard (5)
2025 BioForest Digital (3)
2025 Lone Star Bio Digital (6)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2610)
Accelerated approval (5)
Adcomms (21)
Allergies (87)
Alliances (51505)
ALS (91)
Alzheimer's disease (1394)
Antibody-drug conjugate (ADC) (130)
Approvals (16602)
Artificial intelligence (262)
Autoimmune disease (24)
Automation (16)
Bankruptcy (372)
Best Places to Work (11807)
BIOSECURE Act (21)
Biosimilars (111)
Biotechnology (191)
Bladder cancer (65)
Brain cancer (28)
Breast cancer (274)
Cancer (2191)
Cardiovascular disease (180)
Career advice (1760)
Career pathing (31)
CAR-T (147)
Cell therapy (413)
Cervical cancer (19)
Clinical research (67514)
Collaboration (838)
Compensation (525)
Complete response letters (25)
COVID-19 (2657)
CRISPR (43)
C-suite (239)
Cystic fibrosis (103)
Data (2111)
Decentralized trials (2)
Denatured (28)
Depression (45)
Diabetes (268)
Diagnostics (6449)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (124)
Drug pricing (110)
Drug shortages (28)
Duchenne muscular dystrophy (93)
Earnings (88179)
Editorial (37)
Employer branding (21)
Employer resources (150)
Events (115071)
Executive appointments (722)
FDA (17835)
Featured Employer (51)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (752)
Gene editing (107)
Generative AI (21)
Gene therapy (304)
GLP-1 (745)
Government (4541)
Grass and pollen (5)
Guidances (52)
Healthcare (19077)
Huntington's disease (24)
IgA nephropathy (25)
Immunology and inflammation (124)
Indications (29)
Infectious disease (2800)
Inflammatory bowel disease (138)
Inflation Reduction Act (8)
Influenza (51)
Intellectual property (94)
Interviews (323)
IPO (16790)
IRA (47)
Job creations (4057)
Job search strategy (1500)
Kidney cancer (10)
Labor market (38)
Layoffs (486)
Leadership (17)
Legal (8384)
Liver cancer (73)
Lung cancer (313)
Lymphoma (149)
Machine learning (6)
Management (60)
Manufacturing (310)
MASH (67)
Medical device (13457)
Medtech (13462)
Mergers & acquisitions (20402)
Metabolic disorders (694)
Multiple sclerosis (77)
NASH (17)
Neurodegenerative disease (89)
Neuropsychiatric disorders (29)
Neuroscience (1932)
NextGen: Class of 2025 (6655)
Non-profit (4538)
Northern California (2602)
Now hiring (39)
Obesity (373)
Opinion (230)
Ovarian cancer (74)
Pain (91)
Pancreatic cancer (82)
Parkinson's disease (148)
Partnered (21)
Patents (233)
Patient recruitment (106)
Peanut (49)
People (59292)
Pharmaceutical (91)
Pharmacy benefit managers (19)
Phase I (20940)
Phase II (29695)
Phase III (22269)
Pipeline (1153)
Policy (149)
Postmarket research (2655)
Preclinical (8885)
Press Release (68)
Prostate cancer (101)
Psychedelics (31)
Radiopharmaceuticals (250)
Rare diseases (392)
Real estate (6262)
Recruiting (67)
Regulatory (23122)
Reports (46)
Research institute (2375)
Resumes & cover letters (358)
Rett syndrome (4)
RNA editing (4)
RSV (42)
Schizophrenia (74)
Series A (131)
Series B (84)
Service/supplier (12)
Sickle cell disease (55)
Southern California (2239)
Special edition (15)
Spinal muscular atrophy (150)
Sponsored (30)
Startups (3737)
State (2)
Stomach cancer (14)
Supply chain (69)
Tariffs (36)
The Weekly (50)
United States (22694)
Vaccines (695)
Venture capitalists (41)
Weight loss (250)
Women's health (35)
Worklife (15)
Date
Today (102)
Last 7 days (620)
Last 30 days (2490)
Last 365 days (33297)
2025 (9995)
2024 (35813)
2023 (40660)
2022 (51850)
2021 (56366)
2020 (54871)
2019 (47513)
2018 (35834)
2017 (33185)
2016 (32726)
2015 (38673)
2014 (32563)
2013 (27698)
2012 (29786)
2011 (30529)
2010 (28550)
Location
Africa (783)
Alabama (52)
Alaska (7)
Arizona (237)
Arkansas (14)
Asia (40755)
Australia (6529)
California (5958)
Canada (1980)
China (519)
Colorado (263)
Connecticut (267)
Delaware (141)
Europe (87022)
Florida (885)
Georgia (203)
Idaho (57)
Illinois (539)
India (26)
Indiana (315)
Iowa (10)
Japan (161)
Kansas (102)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (877)
Massachusetts (4479)
Michigan (218)
Minnesota (387)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (60)
New Hampshire (62)
New Jersey (1700)
New Mexico (29)
New York (1697)
North Carolina (971)
North Dakota (7)
Northern California (2602)
Ohio (199)
Oklahoma (14)
Oregon (39)
Pennsylvania (1343)
Puerto Rico (11)
Rhode Island (32)
South America (1165)
South Carolina (22)
South Dakota (1)
Southern California (2239)
Tennessee (101)
Texas (890)
Utah (178)
Virginia (149)
Washington D.C. (62)
Washington State (553)
West Virginia (3)
Wisconsin (54)
718,641 Results for "spectrum pharmaceuticals inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Piccolo Medical, Inc. Announces Distribution Agreement with Spectrum Vascular
January 13, 2025
·
2 min read
Press Releases
Spectrum Vascular Welcomes New Executive Leadership
April 14, 2025
·
4 min read
Press Releases
CLS Health Introduces Full-Spectrum Eye Care at Clear Lake Campus
April 15, 2025
·
2 min read
Pharm Country
A First-In-Class, Broad-Spectrum Antiviral Agent Intending To Revolutionize Treatment of Viral Infections Including RSV, COVID, Influenzas and More
NanoViricides, Inc., a clinical-stage global leader in broad-spectrum antiviral nanomedicines, elaborates on its development of a first-in-class, broad-spectrum antiviral agent that could revolutionize treatment of viral infections including RSV, COVID, Influenzas and other viruses.
May 29, 2024
·
9 min read
Press Releases
Spectrum Dynamics Medical Appoints Tomer Gabay as its New Chief Executive Officer
March 14, 2025
·
1 min read
Pharm Country
A Novel Broad-Spectrum Antiviral with Activity Against Influenza A
NanoViricides, Inc., a global leader in broad-spectrum antiviral nanomedicines, says that the ultra-broad antiviral activity spectrum of NV-387 includes Influenza A viruses, possibly including Bird Flu H5N1 virus as well.
May 6, 2024
·
8 min read
Pharm Country
A Novel Broad-Spectrum Antiviral with Activity Against Smallpox/Mpox
NanoViricides, Inc., a global leader in broad-spectrum antiviral nanomedicines, says that the ultra-broad antiviral activity spectrum of NV-387 includes activity against orthopoxvirus family, with both inhalation and skin abrasion modes of infection acquisition.
May 8, 2024
·
8 min read
Deals
Assertio Holdings, Inc. Closes Spectrum Pharmaceuticals Transaction
Assertio Holdings, Inc., a specialty pharmaceutical company offering differentiated products to patients, announced that it has closed the proposed acquisition of Spectrum Pharmaceuticals, Inc., a biopharmaceutical company focused on novel and targeted oncology.
July 31, 2023
·
5 min read
Pharm Country
A Novel Broad-Spectrum Antiviral with Activity Against RSV
NanoViricides, Inc., a global leader in broad-spectrum antiviral nanomedicines, says that antiviral activity of NV-387 against RSV/A2 is strong enough to have resulted in full survival of lethally infected animals was achieved.
May 14, 2024
·
7 min read
Pharm Country
A Novel Broad-Spectrum Antiviral Against Influenza A Viruses, NV-387, Could Be an Important Weapon to Fight Bird Flu H5N1, Says NanoViricides
NanoViricides, Inc., a clinical stage global leader in broad-spectrum antiviral nanomedicines, comments that the ultra-broad-spectrum antiviral NV-387 could be an important weapon against bird flu H5N1 viruses.
June 24, 2024
·
8 min read
1 of 71,865
Next
